168 related articles for article (PubMed ID: 16679722)
21. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
Khouri JM; Motter RN; Arnon SS
Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762
[TBL] [Abstract][Full Text] [Related]
22. Botulism among penned pheasants and protection by vaccination with C1 toxoid.
Kurazono H; Shimozawa K; Sakaguchi G; Takahashi M; Shimizu T; Kondo H
Res Vet Sci; 1985 Jan; 38(1):104-8. PubMed ID: 3883454
[TBL] [Abstract][Full Text] [Related]
23. Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines.
Chellapandi P; Prisilla A
Curr Protein Pept Sci; 2017; 18(5):412-424. PubMed ID: 27915984
[TBL] [Abstract][Full Text] [Related]
24. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
[TBL] [Abstract][Full Text] [Related]
25. Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle.
Gregory AR; Ellis TM; Jubb TF; Nickels RJ; Cousins DV
Aust Vet J; 1996 Feb; 73(2):55-61. PubMed ID: 8660200
[TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
[TBL] [Abstract][Full Text] [Related]
27. Botulism and vaccines for its prevention.
Smith LA
Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
[TBL] [Abstract][Full Text] [Related]
28. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
Shi DY; Chen BY; Mao YY; Zhou G; Lu JS; Yu YZ; Zhou XW; Sun ZW
Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
[TBL] [Abstract][Full Text] [Related]
29. Type C/D botulism in the waterfowl in an urban park in Italy.
Badagliacca P; Pomilio F; Auricchio B; Sperandii AF; Di Provvido A; Di Ventura M; Migliorati G; Caudullo M; Morelli D; Anniballi F
Anaerobe; 2018 Dec; 54():72-74. PubMed ID: 30118893
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.
Zichel R; Mimran A; Keren A; Barnea A; Steinberger-Levy I; Marcus D; Turgeman A; Reuveny S
Clin Vaccine Immunol; 2010 May; 17(5):784-92. PubMed ID: 20357058
[TBL] [Abstract][Full Text] [Related]
31. Preliminary evaluation of a simple in vitro test for the diagnosis of type C botulism in wild birds.
Rocke TE; Smith SR; Nashold SW
J Wildl Dis; 1998 Oct; 34(4):744-51. PubMed ID: 9813844
[TBL] [Abstract][Full Text] [Related]
32. An adenoviral vector-based mucosal vaccine is effective in protection against botulism.
Xu Q; Pichichero ME; Simpson LL; Elias M; Smith LA; Zeng M
Gene Ther; 2009 Mar; 16(3):367-75. PubMed ID: 19129860
[TBL] [Abstract][Full Text] [Related]
33. Chronic botulism in a Saxony dairy farm: sources, predisposing factors, development of the disease and treatment possibilities.
Krüger M; Neuhaus J; Herrenthey AG; Gökce MM; Schrödl W; Shehata AA
Anaerobe; 2014 Aug; 28():220-5. PubMed ID: 24997242
[TBL] [Abstract][Full Text] [Related]
34. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge.
Kim NY; Ahn HB; Yu CH; Song DH; Hur GH; Shin YK; Shin S
Hum Vaccin Immunother; 2019; 15(2):412-419. PubMed ID: 30235058
[TBL] [Abstract][Full Text] [Related]
35. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
Gao YL; Gao S; Kang L; Nie C; Wang JL
Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
[TBL] [Abstract][Full Text] [Related]
36. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
[TBL] [Abstract][Full Text] [Related]
37. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism.
Steinman A; Chaffer M; Elad D; Shpigel NY
Clin Vaccine Immunol; 2006 Aug; 13(8):862-8. PubMed ID: 16893985
[TBL] [Abstract][Full Text] [Related]
39. An improved method for development of toxoid vaccines and antitoxins.
Jones RG; Liu Y; Rigsby P; Sesardic D
J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
[TBL] [Abstract][Full Text] [Related]
40. Outbreaks of type C botulism in waterfowl in Japan.
Ono T; Azuma R; Kato T; Takeuchi S; Suto T
Natl Inst Anim Health Q (Tokyo); 1982; 22(3):102-14. PubMed ID: 6761593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
